Ingrid Holst

515 total citations · 1 hit paper
5 papers, 359 citations indexed

About

Ingrid Holst is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ingrid Holst has authored 5 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ingrid Holst's work include Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetes Management and Research (2 papers). Ingrid Holst is often cited by papers focused on Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Diabetes Management and Research (2 papers). Ingrid Holst collaborates with scholars based in Denmark, United States and United Kingdom. Ingrid Holst's co-authors include Bernhard Ludvik, Athena Philis‐Tsimikas, Desirée Thielke, Vincent Woo, Vaishali Bhosekar, Bernard Zinman, James Thrasher, Robert S. Busch, Ildiko Lingvay and Stephen C. Bain and has published in prestigious journals such as Diabetes, European Heart Journal and The Lancet Diabetes & Endocrinology.

In The Last Decade

Ingrid Holst

5 papers receiving 350 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial

2019 267 citations Bernard Zinman, Vaishali Bhosekar et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingrid Holst Denmark	3	337	195	90	69	43	5	359
Milivoj Piletič Denmark	6	435 1.3×	256 1.3×	86 1.0×	104 1.5×	36 0.8×	10	461
Masakazu Takeuchi Japan	13	479 1.4×	256 1.3×	130 1.4×	128 1.9×	72 1.7×	29	550
Magnus F.G. Grøndahl Denmark	7	352 1.0×	169 0.9×	48 0.5×	207 3.0×	52 1.2×	13	419
Knut Robert Andersen Germany	5	344 1.0×	175 0.9×	60 0.7×	162 2.3×	25 0.6×	5	374
Lingli Zhou China	7	186 0.6×	90 0.5×	39 0.4×	78 1.1×	33 0.8×	17	251
Elizabeth Bandeira-Echtler Germany	4	345 1.0×	156 0.8×	49 0.5×	116 1.7×	35 0.8×	5	409
Guillaume Frappin Switzerland	3	274 0.8×	148 0.8×	47 0.5×	145 2.1×	25 0.6×	5	329
Charlotte C. van Ruiten Netherlands	8	223 0.7×	95 0.5×	59 0.7×	82 1.2×	42 1.0×	9	275
Michito Ubukata Japan	8	295 0.9×	166 0.9×	52 0.6×	118 1.7×	18 0.4×	9	316
Surya Panicker Rajeev United Kingdom	7	232 0.7×	108 0.6×	54 0.6×	107 1.6×	49 1.1×	14	285

Countries citing papers authored by Ingrid Holst

Since Specialization

Citations

This map shows the geographic impact of Ingrid Holst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Holst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Holst more than expected).

Fields of papers citing papers by Ingrid Holst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Holst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Holst. The network helps show where Ingrid Holst may publish in the future.

Co-authorship network of co-authors of Ingrid Holst

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Holst. A scholar is included among the top collaborators of Ingrid Holst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Holst. Ingrid Holst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Buse, John B., Ingrid Holst, Filip K. Knop, et al.. (2021). Prototype of an evidence‐based tool to aid individualized treatment for type 2 diabetes. Diabetes Obesity and Metabolism. 23(7). 1666–1671. 4 indexed citations

2.

Vilsbøll, Tina, et al.. (2020). 2187-PUB: Identifying Risk Predictors for Gastrointestinal Adverse Events with Once-Weekly Semaglutide. Diabetes. 69(Supplement_1). 1 indexed citations

3.

Leiter, Lawrence A., Stephen C. Bain, Irene Hramiak, et al.. (2019). Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial. Cardiovascular Diabetology. 18(1). 73–73. 86 indexed citations

4.

Zinman, Bernard, Vaishali Bhosekar, Robert S. Busch, et al.. (2019). Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial. The Lancet Diabetes & Endocrinology. 7(5). 356–367. 267 indexed citations breakdown →

5.

Desouza, Cyrus, Stephen C. Bain, Thomas K. Hansen, et al.. (2019). P6271The effect of semaglutide once weekly on MACE and blood pressure by race and ethnicity: SUSTAIN 6 post hoc analysis. European Heart Journal. 40(Supplement_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact